KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Times Interest Earned: 2017-2022

Historic Times Interest Earned for Sarepta Therapeutics (SRPT) over the last 6 years, with Dec 2022 value amounting to -$15.97.

  • Sarepta Therapeutics' Times Interest Earned fell 68.52% to -$15.97 in Q4 2022 from the same period last year, while for Dec 2022 it was -$9.64, marking a year-over-year decrease of 33.40%. This contributed to the annual value of -$12.17 for FY2023, which is 20.84% down from last year.
  • Latest data reveals that Sarepta Therapeutics reported Times Interest Earned of -$15.97 as of Q4 2022, which was down 79.20% from -$8.91 recorded in Q3 2022.
  • Sarepta Therapeutics' Times Interest Earned's 5-year high stood at -$1.67 during Q3 2021, with a 5-year trough of -$37.08 in Q2 2019.
  • Moreover, its 3-year median value for Times Interest Earned was -$9.52 (2020), whereas its average is -$9.25.
  • Per our database at Business Quant, Sarepta Therapeutics' Times Interest Earned spiked by 97.36% in 2018 and then slumped by 434.17% in 2022.
  • Quarterly analysis of 5 years shows Sarepta Therapeutics' Times Interest Earned stood at -$19.23 in 2018, then tumbled by 42.73% to -$27.44 in 2019, then surged by 66.78% to -$9.11 in 2020, then decreased by 4.00% to -$9.48 in 2021, then plummeted by 68.52% to -$15.97 in 2022.
  • Its Times Interest Earned was -$15.97 in Q4 2022, compared to -$8.91 in Q3 2022 and -$12.45 in Q2 2022.